| HOME | New Additions | NEWS ITEMS | ARTICLES | LETTERS FROM THE PAPERS -and DoH, MPs & Press Emails | ODDS & SODS | LINKS | CONTACT |
Membership of SCOTH
Register of members' interests
From http://www.advisorybodies.doh.gov.uk/scoth/members.htm
| PROFESSOR RICHARD CARTER CBE | ||||||||||
Retired. Formerly Visiting Professor
of Pathology, School of Biological Science, University of
Surrey, Consultant Histopathologist, Royal Marsden
Hospital. |
||||||||||
| Non
commercial interests |
||||||||||
| Consultant to
Thames Cancer Registry |
||||||||||
| Political
Activity: None declared |
| PROFESSOR
ILANA CROME Harplands Hospital, Stoke on Trent |
|
| Date
of birth: |
2nd
February 1951 |
| Gender:
|
Female |
| Date
of appointment: |
July
2000 - July 2003 |
| Occupational
group: |
Health
professional |
| Status:
|
Member
of SCOTH |
| Commercial
Interests (including shareholdings) |
| Received
hotel expenses from Merck for a meeting on alcohol in
Lisbon 1998 and in London 2000 where she was a speaker.
Costs from Boehringer (£300) and Schering Plough (£300)
- fees for speaking at symposia. Travel expenses from
Merck Lipha (Strasbourg 1999). Has shares with Novartis
and Roche |
| Non
commercial interests |
| |
| Political
Activity: Labour |
PROFESSOR GODFREY FOWLER Emeritus Professor of General
Practice, University of Oxford
| Date of
birth: |
1 October
1931 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| No
shareholdings. Chaired a smoking cessation group funded
by an educational grant from Novartis but no
consultancies. Emeritus Professor of General Practice,
University of Oxford. GP Consultant to ICRF (one session
a week based in the ICRF General Practice Research Group.
|
| Non
commercial interests |
| Interests in
preventive medicine, particular CVD and Cancer and
tobacco control. 20 years experience in smoking cessation
research and practice. GP in Oxford for nearly 40 years.
On the Councils of the British Heart Foundation and
Stroke Association and Executive Board of ASH. Also on
COMA and SCOTH. |
| Political
Activity: None declared |
PROFESSOR JAMES FRIEND
Consultant Respiratory Physician,
Aberdeen Royal Infirmary
| Date of
birth: |
2nd June 1938 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Chair SCOTH |
| Commercial
Interests (including shareholdings) |
| Attended
European Respiratory Society Annual Conference in
Florence, September 20000 and World Conference on Smoking
or Health in Chicago, August 2000, supported by Glaxo UK
Ltd at no personal financial gain. No consultancies. Employed full time as Consultant in thoracic medicine, Grampian University Hospitals NHS Trust, Aberdeen, since 1973. Honorary Clinical Professor in medicine and therapeutics, Aberdeen University since 1998. |
| Non
commercial interests |
| Interest in
clinical respiratory medicine, particularly asthma, and
the organisation of care. Commitment to health promotion,
and prevention of disease. Research interests in asthma,
smoking cessation and prevention. Board member, Grampian
Heart Campaign (charitable body); Medical Adviser
National Asthma Campaign, Scotland. Member, Research
Committee, Chest Heart and Stroke, Scotland. |
| Political
Activity: None declared |
PROFESSOR A HAMID GHODSE
Department of Addictive Behaviour and Psychological Medicine
St George's Hospital Medical School
| Date of
birth: |
30th April
1938 |
| Gender:
|
Male
|
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| PEP bank and
building society windfalls. Has always worked full time
in the NHS/University with no private practice. No links
formally or informally with any drug companies or the
tobacco and alcohol industry. |
| Non
commercial interests |
| Member of the
Royal College of Psychiatrists, Royal College of Physicians of London and Edinburgh. Member of Faculty of Public Health Medicine and member of the Executive Committee (one of the directors) on Medical Council on Alcoholism. Advisor, Joint Formulary Committee, British National Formulary. President of the International Narcotics Control Board. Member of World Health Organisation (WHO) Expert Advisory Panel on Drug Dependence and Alcohol Problems. |
| Political
Activity: None declared |
PROFESSOR CHRISTINE GODFREY
Department of Health Sciences and Clinical Evaluation
University of York
| Date of
birth: |
27th June
1950 |
| Gender: |
Female |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| President of
Society for the Study of Addiction (registered charity).
Trustee, Alcohol and Health Research Centre, Edinburgh.
Received lecture fees from various universities,
reviewing work etc, less than £300 in 1999/00 |
| Non
commercial interests |
| Attended
Pharmaceutical company dinners at 2 conferences. Received
occasional payments from management consultation
companies for research advice on alcohol and tobacco
related issues paid into University of York, less than
£1,000 in 1999/00. Grant of £20,000 from Reckitt and
Coleman Ltd in 1997 for analysis of costs and benefits of
illicit drug treatments in Europe. |
| Political
Activity: None declared |
PROFESSOR ROGER GREENHALGH Professor of Surgery,
Imperial College of School of Medicine
Charing Cross Hospital
| Date
of birth: |
|
| Gender:
|
Male
|
| Date
of appointment: |
July
2000 - July 2003 |
| Occupational
group: |
Health
professional |
| Status:
|
Member
SCOTH |
| Commercial
Interests (including shareholdings) |
| Professor of
Surgery. Receives grants from the Medical Research
Council and British Heart Foundation. Trustee of the
British Vascular Foundation and President elect of the
Vascular Surgical Society of Great Britain and Ireland.
President from 1998-2002 of the Section of Surgery of the
UEMS for the European Union. Director of a company, Biba
Medical which organises an annual symposium which
publishes an annual book and newspaper. |
| Non
commercial interests |
| Lead
applicant for the Medical Research Council UK Small
Aneurysm Trial. This shows that aortic aneurysm dilate
faster in patients who smoke. Researched relentlessly on
the effect of tobacco smoke and arterial disease for 30
years but have never been a member of an action group
such as ASH. Lead applicant for the NHS R&D EVAR
Trials for endovascular aneurysm repair which is
described as the largest surgical trial of all time in
the UK. Just been elected to the Health Services Board of
the Medical Research Council. The only surgeon to serve
since Sir Miles Irving. |
| Political
Activity: None declared |
PROFESSOR MARION HALL Consultant Obstetrician and
Gynaecologist
Aberdeen Maternity Hospital
| Date of
birth: |
5th September
1934 |
| Gender: |
Female |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| Consultant
Obstetrician & Gynaecologist. Full time NHS employee.
Currently in receipt of research grants from the Scottish
Health Services Research Committee, the Department for
International Development and the British Heart
Foundation. |
| Non
commercial interests |
| Previously
served as a member of the Centre for Research and
Development Committee for the National Health Service and
is the current chair of the Scottish Health Services
Research Committee (part of the Chief Scientist
organisation in Scotland). Senior Regional Adviser to the Scottish Advisory Committee for Distinction Awards. Previously chaired the RCOG Audit Committee. Member of the WHO Expert Panel for Mother and Child Health and a member of the FIGO Advisory Panel on Epidemiology. |
| Political
Activity: None declared |
PROFESSOR TIM HIGENBOTTAM BSc MBBS MA MD DSc FRCP
| Post |
Global
Clinical Expert AstraZeneca R&D |
| Date of
birth: |
12th March
1947 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
|
| Status: |
Member SCOTH
& TAG |
| Formerly: |
Visiting
Professor of Medicine Medicine and Pharmacology Division of Clinical Science University of Sheffield |
| Commercial
Interests (including shareholdings) |
| None other
than employer from January 2000. |
| Non
commercial interests |
| 1. Past
chairman of the Pulmonary Circulation Working group
European Society of Cardiology. 2. Leading investigator: Framework Five EU Commission Grant, COPHIT "The modelling and validation of the model of inhaled aerosols and gases" Including: University of Mainz, AEA Technology Ltd, Aventis PLC, Messer PLC, Areco PLC and the University of Sheffield. (1.5 million ecu) 3. Site investigator: Framework Five EU Commission Grant, PHIL "Functional imaging of the lungs with Magnetic Resonance with special reference to chronic obstructive lung disease" Including: Mainz University, Laboratoire Kastler Brossel Department de Physique de lEcole Normale Superieure Paris, University Sheffield. |
| Political
Activity: Labour |
PROFESSOR MARTIN JARVIS
Cancer Research UK Health Behaviour Unit
Department of Epidemiology and Public Health
University College London Medical School
| Date of
birth: |
30th June
1939r |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Chair |
| Commercial
Interests (including shareholdings) |
| Assistant
director, ICRF Health Behaviour Unit. Has received
honoraria for speaking from several pharmaceutical
companies with smoking cessation products including
Pharmacia and Upjpohn, Novartis, SmithKline Beecham and
Glaxo. Has also done ad hoc consultancy for Pharmacia and
Upjohn. Has no shareholdings and no research funding with
either companies. Member of Scientific Advisory Board,
Star Scientific. |
| Non
commercial interests |
| Director of
ASH and on the Executive Council of the Society for the
Study of Addiction. Member of Scientific Advisory
Committee on Tobacco, World Health Organisation. |
| Political
Activity: Labour |
PROFESSOR NEWELL JOHNSON Department of Oral and
Maxillofacial Medicine and Pathology
Guy's, King's and St Thomas' Schools of Medicine, Dentistry and
Biomedical Sciences
| Date of
birth: |
5th August
1938 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| |
| Non
commercial interests |
| Receives
grants from ZILA Pharmaceuticals Ltd for studies on the
use of Tolonium Chloride in screening for oral cancer. |
| Political
Activity: None declared |
DR STUART LOGAN Institute of Child Health and Great Ormond
Street Hospital for Children NHS Trust
University College London Medical School
| Date of
birth: |
12th March
1955 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| Editor of
Child: Care, Health and Development for which I am paid a
small honorarium. |
| Non
commercial interests |
| Member of the
following: Childhood sub-group of the National Screening
Committee (DH), Royal College of Paediatrics and Child
Health, War on Want. |
| Political
Activity: Labour |
PROFESSOR SIR RICHARD PETO Clinical Trial Service Unit
and Epidemiology Unit
Oxford University
| Date of
birth: |
14th May 1943 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| None. (RCTs
run by the CTSU receive grants to the University of
Oxford from particular pharmaceutical companies).
Professor of Medical Statistics and Epidemiology ICRF,
Oxford University since 1992. All donations to Oxfam and
Amnesty International. |
| Non
commercial interests |
| |
| Political
Activity: None declared |
PROFESSOR DAVID PURSER
Fire Research Station
Building Research Establishment
| Date of
birth: |
|
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| Employed by
The Building Research Establishment Ltd. This is former
DETR Agency, now a non-profit making foundation. BRE Ltd
carries out research and consultancy related to buildings
for various government bodies (principally DETR) and
commercial customers. Has shares with: British Airport
Authority, British Telecom, Cable and Wireless,
Lloyds-TSB, Reckitt, Allied Domecq, Reckitt Benkister |
| Non
commercial interests |
| Member DoH,
Health Advisory Group on Chemical Contamination Incidents
- working subgroup on environmental hazards from smoke
toxins. Chairman: British Standards Institution Committee
FSH/16 (Hazards to Life in Fire), Chairman: British
Standards Institution Panel H/-/2/2 Co-ordination of fire
safety. Visiting Professor of Fire Safety and Toxicology, University of Greenwich, Department of Mathematics and Computing. Visiting Fellow - University of Salford, Department of Chemistry and Applied Chemistry. |
| Political
Activity: None declared |
PROFESSOR ROSALIND L SMYTH - MA MBBS FRCPCH MD
Brough Professor of Paediatric Medicine
Department of Child Health
Institute of Child Health
Alder Hey Children's Hospital Liverpool
| Date of
birth: |
28th
September 1958 |
| Gender: |
Female |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
| Commercial
Interests (including shareholdings) |
| Sponsorship
to attend medical/scientific conferences at Solvay
Healthcare and Glaxo-Wellcome. Honoraria and travel
expenses for presenting at and attending meetings at
Merck Sharp & Dohme, Astra Zeneca, Solvay Healthcare,
Glaxo-Wellcome and Pharmax. Sponsorship to enable members
of my research group to attend medical/scientific
conferences at Solvay Healthcare, Roche Products Ltd and
Glaxo-Wellcome. |
| Non
commercial interests |
| Chairperson
of Cystic Fibrosis Trust Clinical Trials Advisory Group
from 1998 to present. On the Executive Committee of the
Royal College of Paediatrics and Child Health, Research
Unit from 1998 to present. Member of the Advisory Board,
Cochrane Child Health Field from 1998 to present. Member
of the Scientific Advisory Panel, Action Research from
1999 to present. Member of BTS/SIGN Asthma Guidelines
Executive Committee and Steering Committee from 2000 to
present. Member of the Committee on Safety of Medicines,
Subgroup on Paediatric Medicine from 2000 to present. |
| Political
Activity: None declared |
PROFESSOR NICHOLAS WALD
Department of Environment and Preventive Medicine
Wolfson Institute of Preventive Medicine
St Bartholomew's and the Royal London School of Medicine and
Dentistry
| Date of
birth: |
|
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member SCOTH |
PROFESSOR NICHOLAS WALD Department of
Environment and Preventive Medicine Wolfson Institute of
Preventive Medicine St Bartholomew's and the Royal London School
of Medicine and Dentistry Date of birth: Gender: Male Date of
appointment: July 2000 - July 2003 Occupational group: Health
professional Status: Member SCOTH Commercial Interests (including
shareholdings) Director of Logical Medical Systems Non commercial
interests His department receives drugs free of charge from Wyeth
Lederle in connection with a randomised trial being conducted in
the department. Political Activity: None declared.
| Commercial
Interests (including shareholdings) |
| Director of
Logical Medical Systems Non commercial interests His
department receives drugs free of charge from Wyeth
Lederle in connection with a randomised trial being
conducted in the department. Political Activity: |
| Non
commercial interests |
| His
department receives drugs free of charge from Wyeth
Lederle in connection with a randomised trial being
conducted in the department. |
| Political
Activity: None declared. |
TAG Register of members' interests – Technical
Advisory Group
From http://www.advisorybodies.doh.gov.uk/scoth/technicaladvisorygroup/member.htm
PROFESSOR RICHARD CARTER CBE |
||||||||||
Retired. Formerly Visiting Professor
of Pathology, School of Biological Science, University of
Surrey, Consultant Histopathologist, Royal Marsden
Hospital. |
||||||||||
| Non
commercial interests |
||||||||||
| Consultant to
Thames Cancer Registry |
||||||||||
| Political
Activity: None declared |
PROFESSOR FRANK FAIRWEATHER
| Date of
birth: |
2nd May 1928 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Observer |
| Commercial
Interests (including shareholdings) |
| Retired.
Previously of BIBRA (Director of Clinical Studies and
Head of Pathology) and part time Scientific Consultant to
Department of Health Tobacco Policy Unit |
| Non
commercial interests |
| Member of
MIND. Keen angler. Fellow of RSA. Member of National
Trust. |
| Political
Activity: None declared |
PROFESSOR TIM HIGENBOTTAM BSc MBBS MA MD DSc FRCP
| Post |
Global
Clinical Expert AstraZeneca R&D |
| Date of
birth: |
12th March
1947 |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
|
| Status: |
Member |
| Formerly: |
Visiting
Professor of Medicine Medicine and Pharmacology Division of Clinical Science University of Sheffield |
| Commercial
Interests (including shareholdings) |
| None other
than employer from January 2000. |
| Non
commercial interests |
| 1. Past
chairman of the Pulmonary Circulation Working group
European Society of Cardiology. 2. Leading investigator: Framework Five EU Commission Grant, COPHIT "The modelling and validation of the model of inhaled aerosols and gases" Including: University of Mainz, AEA Technology Ltd, Aventis PLC, Messer PLC, Areco PLC and the University of Sheffield. (1.5 million ecu) 3. Site investigator: Framework Five EU Commission Grant, PHIL "Functional imaging of the lungs with Magnetic Resonance with special reference to chronic obstructive lung disease" Including: Mainz University, Laboratoire Kastler Brossel Department de Physique de lEcole Normale Superieure Paris, University Sheffield. |
| Political
Activity: Labour |
PROFESSOR MARTIN JARVIS
Cancer Research UK Health Behaviour Unit
Department of Epidemiology and Public Health
University College London Medical School
| Date of
birth: |
30th June
1939r |
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Chair |
| Commercial
Interests (including shareholdings) |
| Assistant
director, ICRF Health Behaviour Unit. Has received
honoraria for speaking from several pharmaceutical
companies with smoking cessation products including
Pharmacia and Upjpohn, Novartis, SmithKline Beecham and
Glaxo. Has also done ad hoc consultancy for Pharmacia and
Upjohn. Has no shareholdings and no research funding with
either companies. Member of Scientific Advisory Board,
Star Scientific. |
| Non
commercial interests |
| Director of
ASH and on the Executive Council of the Society for the
Study of Addiction. Member of Scientific Advisory
Committee on Tobacco, World Health Organisation. |
| Political
Activity: Labour |
MR JOHN McAUGHEY
Independent Consultant (formerly AEA Technology Environment)
| Date of
birth: |
|
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member TAG |
| Commercial
Interests (including shareholdings) |
| Manager,
Health related Aerosols, Salaried employee of AEA
Technology, Employee shareholder of AEA Technology.
Conducted scientific work in the field of tobacco smoke
exposure and dosimetry (active and passive smoking) for
the following organisations: Tobacco Products Research Trust (via UK DoH) UK Department of Environment, Transport and Regions (DETR) Center for Indoor Air Research (US), Rothmans International Tobacco (UK), Gallaher plc (UK), Filtrona (UK), Tobacco Manufacturers Association (UK) Other work for DoH in the fields of particulate air pollution, and population radiological protection. |
| Non
commercial interests |
| Member of
Particles Sub-Group of DoH Committee of Medical Effects
of Air Pollutants (COMEAP) (1993-1995). Member of
Airborne Particles Expert Group (APEG) of DETR
(1997-1998). Chartered Chemist, Member of the Royal
Society of Chemistry. Member of Aerosol Society,
Association of Inhalation Toxicologists, American
Association for Aerosol Research, International Society
for Aerosols in Medicine and Ex-director of Fleetway
Residents Association. |
| Political
Activity: None declared |
PROFESSOR DAVID PURSER
Fire Research Station
Building Research Establishment
| Date of
birth: |
|
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member |
| Commercial
Interests (including shareholdings) |
| Employed by
The Building Research Establishment Ltd. This is former
DETR Agency, now a non-profit making foundation. BRE Ltd
carries out research and consultancy related to buildings
for various government bodies (principally DETR) and
commercial customers. Has shares with: British Airport
Authority, British Telecom, Cable and Wireless,
Lloyds-TSB, Reckitt, Allied Domecq, Reckitt Benkister |
| Non
commercial interests |
| Member DoH,
Health Advisory Group on Chemical Contamination Incidents
- working subgroup on environmental hazards from smoke
toxins. Chairman: British Standards Institution Committee
FSH/16 (Hazards to Life in Fire), Chairman: British
Standards Institution Panel H/-/2/2 Co-ordination of fire
safety. Visiting Professor of Fire Safety and Toxicology, University of Greenwich, Department of Mathematics and Computing. Visiting Fellow - University of Salford, Department of Chemistry and Applied Chemistry. |
| Political
Activity: None declared |
PROFESSOR MARY J SELLER
Division of Medical and Molecular Genetics
Guy's, King's and St Thomas' School of Medicine and Dentistry
| Date of
birth: |
|
| Gender: |
Female |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member |
| Commercial
Interests (including shareholdings) |
| Shares in
Marks & Spencer, British Telecom and Abbey National.
Lecture fees from British Meat Federation Education
Department. |
| Non
commercial interests |
| Professor of
Developmental Genetics. Member of the COMA Working Group
on the Nutritional Status of the Population Subgroup on
Folic Acid - work now completed. Inspector for the Human
Fertilisation and Embryology Authority, Advisor on folic
acid and NTD prevention to the HEA (now disbanded).
Former president of the Developmental Pathology Society.
Governor of the Royal Wanstead Foundation. Priest in the
Church of England. |
| Political
Activity: None declared |
MRS CHERYL SWANN
| Date of
birth: |
|
| Gender: |
Female |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Observer |
| Commercial
Interests (including shareholdings) |
| Have held no
shares since August 1999. Has private pension with Eagle
Star. Worked part-time for FSIDS as a Research Grants
Administrator until 31st October 2000, then full-time at
the Wolfson unit of Environmental & Preventive
Medicine, St. Bartholomew's from 1st November 2000. |
| Non
commercial interests |
| |
| Political
Activity: None declared |
DR STAN VENITT
Haddow Laboratories
Section of Molecular Carcinogenesis
Institute of Cancer Research
| Date of
birth: |
|
| Gender: |
Male |
| Date of
appointment: |
July 2000 -
July 2003 |
| Occupational
group: |
Health
professional |
| Status: |
Member |
| Commercial
Interests (including shareholdings) |
| Abbey
National plc, Northern Rock plc, Bradford & Bingley
plc. |
| Non
commercial interests |
| Retired. A
scientific consultant and Emeritus Reader in the
Institute of Cancer Research which is a charity, not for
profit, Company limited by Guarantee and an Associate
Institution of the University of London. A former member of the DoH Committee on Mutagenicity and DoH Committee on Carcinogenicity. |
| Political
Activity: None declared |